{"id":"W2946997709","doi":"10.1200/jco.2019.37.15_suppl.9048","title":"Patient-reported outcomes (PROs) with first-line durvalumab (D) ± tremelimumab (T) versus chemotherapy (CT) in metastatic NSCLC: Results from MYSTIC.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Lung cancer; Internal medicine; Repeated measures design; Quality of life (healthcare); Tremelimumab; Chemotherapy; Population; Oncology; Nuclear medicine; Gastroenterology; Surgery; Cancer; Immunotherapy; Ipilimumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002963188,0.0006425422,0.001457162,0.0002823335,0.0001841912,0.0005489172,0.0006014449,0.0006717393,0.001839991],"category_scores_gemma":[0.001776387,0.0002308888,0.002850566,0.0003567381,0.0004445346,0.0005435461,0.0004450347,0.001481217,0.0002771356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008782814,"about_ca_system_score_gemma":0.0006729563,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004520258,"about_ca_topic_score_gemma":0.0009137013,"domain_scores_codex":[0.9990053,0.0005770024,0.00006437673,0.0001306029,0.0001260593,0.00009660442],"domain_scores_gemma":[0.9983903,0.0005195533,0.0005853896,0.0001209454,0.00007362271,0.0003101128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8795065,0.005616199,0.01593253,0.001050751,0.005129181,0.00004609292,0.00009920225,0.001559806,0.003682798,0.0001439331,0.001572341,0.08566073],"study_design_scores_gemma":[0.3791357,0.4765584,0.1267745,0.0001964098,0.008112222,0.0002758348,0.0001093849,0.003120613,0.002773649,0.0003904724,0.002494674,0.00005819857],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939016,0.00362351,0.0002189543,0.0001772613,0.0000508419,0.0003144846,0.001162345,0.00002263315,0.0005283967],"genre_scores_gemma":[0.9949495,0.001378165,0.0005222741,0.0003574929,0.0001053501,0.0006560594,0.001591397,0.000007209574,0.0004325792],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002963188,"threshold_uncertainty_score":0.01567101,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08890860114174669,"score_gpt":0.4595490581262037,"score_spread":0.370640456984457,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}